- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: SNDL to Buy Valens
M&A made a big return to the cannabis public market scene this past trading week.
Splashy acquisitions came up in the cannabis industry this week as key players confirmed two major deals.
These significant announcements potentially signal that M&A activity has been reignited in the market.
Keep reading to find out more cannabis highlights from the past five days.
New merger brings together two Canadian cannabis entities
One of the deals in the spotlight this week was SNDL's (NASDAQ:SNDL) planned acquisition of The Valens Company (NASDAQ:VLNS,TSX:VLNS) for nearly C$140 million.
Zach George, CEO of SNDL, previously known as Sundial Growers, pointed to an existing business partnership as the bedrock behind the deal between SNDL and Valens. The executive said his company’s operations will be “transformed” by Valens’ procedures for cannabis product development and production.
"This powerful combination will result in the creation of a dominant vertically integrated company, exceptionally well-suited to weather the current cannabis environment and become a leader in the Canadian regulated products sector," George said in a press released shared on Monday (August 22).
For his part, Valens CEO Tyler Robson said the deal will bring investors exposure to a revenue-generating cannabis company “trading well under its tangible book value.”
Deal gives Canadian producer non-cannabis exposure
Also this week, Aurora Cannabis (NASDAQ:ACB,TSX:ACB) announced it will buy a controlling interest in Bevo Agtech, a supplier of propagated vegetables and ornamental plants.
The Canadian cannabis producer will pay for this deal through an undisclosed subsidiary; it will cost approximately C$45 million, with up to an additional C$12 million paid over the next three years.
As part of the deal, Bevo will acquire Aurora’s grow facility, dubbed Aurora Sky, in Edmonton, Alberta.
“Bevo's track record in generating not only positive Adjusted EBITDA but free cash flow, world class propagation expertise, and established distribution networks in Canada and the United States makes them an ideal strategic partner," Miguel Martin, CEO of Aurora, said.
Cannabis company news
- TerrAscend (CSE:TER,OTCQX:TRSSF)completed an acquisition strategy worth nearly US$30 million for Michigan-based cannabis dispensary operator KISA Enterprises MI, which manages the Pinnacle chain of stores. The deal will bring six stores into the TerrAscend fold.
- Fire & Flower US Holdings, an America-based partner of Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF), completed a non-brokered private placement of unsecured convertible debentures worth US$50 million.
Don't forget to follow us @INN_Cannabis for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.